|
|
|
Hematopoietic stem cells engraft much more efficiently than previously thought. In the July issue of Nature Immunology, Canadian researchers report that every stem cell introduced by transplantation successfully engrafts in the bone marrow. However, only a minority of these established stem cells contribute to long-term hematopoiesis.
Iscove and colleagues show nearly every irradiated mouse that received only one stem cell, on average, can generate blood cells of donor origin within the first 4-8 weeks, signaling successful engraftment. But when these mice were analyzed 32 weeks later, only 25% generated donor blood cells, suggesting that a loss of stem cell self-renewal occurred. Thus, long-term hematopoietic stem cell potential does not appear to be limited by their engraftment success, rather it reflects the variable ability to self-renew once established in the bone marrow. Author contact: Norman N. Iscove
The Ontario Cancer Institute
University of Toronto
Ontario, Canada
Tel: +1 416 946 4501 ext 4987
E-mail: iscove@uhnres.utoronto.ca Also available online. (C) Nature Immunology press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|